产品名称 | NebuSelect™ Recombinant Mouse DSG3, His-tag |
---|---|
目录号 | NBL-241032 |
别名 | DSG3; Desmoglein-3; PVA; CDHF6; SG3; DSG3 |
外观 | see COA |
分子量 | Glu50-Pro617 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O35902-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241032-100ug | 100ug | Inquire | Inquire | |
NBL-241032-1mg | 1mg | Inquire | Inquire | |
NBL-241032-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse DSG3, His-tag
Catalog#:
NBL-241032
Description:
NebuSelect™ Recombinant Mouse DSG3, His-tag(Cat#NBL-241032) is expressed in HEK293 with His tag at the C-Terminus.It contains Glu50-Pro617.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 64.3 kDa. Due to glycosylation, the protein migrates to 70-75 kDa based on Bis-Tris PAGE result.
Target Name:
DSG3; Desmoglein-3; PVA; CDHF6; SG3; DSG3
Target Information:
To identify genes that could potentially serve as molecular therapeutic markers for human head and neck cancer (HNC),DSG3 is identified overexpressed in HNC, with the degree of overexpression associated with clinicopathologic features of the tumor. Inhibition of DSG3 significantly suppresses carcinogenic potential in cellular and in vivo animal studies. DSG3 is a potential molecular target in the development of adjuvant therapy for HNC.
Amino Acid Sequence:
Glu50-Pro617
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.